Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing HYZAAR (losartan/hydrochlorothiazide) with ramipril in patients with type 2 diabetes and hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyzaar (losartan/hydrochlorothiazide)
  • Ramipril (ramipril)

Snippet

Sponsor: Organon and Co | Conditions: Type 2 Diabetes Mellitus, Hypertension | Phase 3 | Status: COMPLETED